Ep. 109: The Impact of Aging on MS: Comorbidities, Polypharmacy and Disease Modifying Treatments

Ep. 109: The Impact of Aging on MS: Comorbidities, Polypharmacy and Disease Modifying Treatments

Moderator: Melinda Magyari (Copenhagen, Denmark) Guest: Thomas Berger (Vienna, Austria) Melinda Magyari and her guest Thomas Berger talk about how aging affects MS progression and management, focusing on immunosenescence's impact on the immune response and DMT effectiveness. They cover the rise of comorbidities in older MS patients, the challenges of using DMTs over age 55, the lack of clinical trials for this age group, and share lifestyle tips to improve quality of life and health outcomes.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(218)

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
romkapsel
liberal-halvtime
rekommandert
rss-nysgjerrige-norge
sinnsyn
rss-paradigmepodden
forskningno
villmarksliv
nevropodden
rss-overskuddsliv
fjellsportpodden
smart-forklart
rss-rekommandert
vett-og-vitenskap-med-gaute-einevoll
tidlose-historier
tomprat-med-gunnar-tjomlid
diagnose